The United States Contract Research Organization (CROs) Market is Anticipated to Exceed USD 54.5 Billion by 2033, growing at a CAGR of 12.03% from 2023 to 2033. The growing number of clinical trials and R&D expenditures in the pharmaceutical and biotechnology industries are driving the growth of the contract research organization (CROs) market in the US.